Emily Sierra-Ordoñez
Research Subjects
Emily Sierra-Ordoñez has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Polo-Barranco
Faculty of Medicine, Universidad Metropolitana de Barranquilla, Barranquilla 080002, Colombia
2 shared publications - Alfonso Bettin Martínez
Universidad Metropolitana
2 shared publications - Carlos Rebolledo-Maldonado
Faculty of Medicine, Universidad Metropolitana de Barranquilla, Barranquilla 080002, Colombia
2 shared publications - Dairo Rodelo-Barrios
Department of Critical Medicine and Intensive Care, Faculty of Medicine, Simón Bolívar University, Barranquilla 080002, Colombia
2 shared publications - Elber Osorio-Rodríguez
Group Care Medicine, Department of Intensive Medicine, Clínica Colsanitas S.A., Clínica Iberoamérica, Barranquilla 080002, Colombia
2 shared publications - Jhonny Patiño-Patiño
Department of Internal Medicine, University of Cartagena, Cartagena de Indias130005, Colombia
2 shared publications
Latest Publications
- Open Access
- 3 April 2024
- Published by MDPI AG in Kidney and Dialysis
- Vol. 4 (2) , 78-92
Acute Kidney Injury Associated with Severe Leptospirosis: Fatal Re-Emerging Disease in Latin America
Leptospirosis is a re-emerging zoonotic disease that has had an unprecedented impact on most health systems in the world. The spectrum of symptoms is variable and usually ranges from asymptomatic cases to severe manifestations involving multiple organ dysfunction accompanied by jaundice, hemorrhage, meningitis, and acute kidney injury that requires the need for intensive care assistance. Although early antibiotic treatment is usually effective, in severe cases, it may require renal replacement therapy, invasive mechanical ventilation, vasoactive support, and invasive hemodynamic monitoring, increasing the risk of death. In Latin America, the real burden of acute kidney injury in this condition is unknown and may be underestimated due to the rapid progression of the disease, similar to other vector zoonoses, and the low coverage of diagnostic tests in primary care, especially in rural regions. Therefore, below, we review the clinical aspects and describe the scientific, clinical, and therapeutic evidence of acute kidney injury attributed to Leptospira spp. and its relevance in patients with severe leptospirosis in Latin America.
- 3 April 2024
- Published by MDPI AG in Kidney and Dialysis
- Vol. 4 (2) , 78-92
Open AccessAcute Kidney Injury Associated with Severe Leptospirosis: Fatal Re-Emerging Disease in Latin America
Leptospirosis is a re-emerging zoonotic disease that has had an unprecedented impact on most health systems in the world. The spectrum of symptoms is variable and usually ranges from asymptomatic cases to severe manifestations involving multiple organ dysfunction accompanied by jaundice, hemorrhage, meningitis, and acute kidney injury that requires the need for intensive care assistance. Although early antibiotic treatment is usually effective, in severe cases, it may require renal replacement therapy, invasive mechanical ventilation, vasoactive support, and invasive hemodynamic monitoring, increasing the risk of death. In Latin America, the real burden of acute kidney injury in this condition is unknown and may be underestimated due to the rapid progression of the disease, similar to other vector zoonoses, and the low coverage of diagnostic tests in primary care, especially in rural regions. Therefore, below, we review the clinical aspects and describe the scientific, clinical, and therapeutic evidence of acute kidney injury attributed to Leptospira spp. and its relevance in patients with severe leptospirosis in Latin America.
- Open Access
- 5 December 2023
- Published by MDPI AG in Preprints.org
Acute Kidney Injury Associated with Severe Leptospirosis: Fatal Re-Emerging Disease in Latin-America
Leptospirosis is a re-emerging zoonotic disease that has had an unprecedented impact on most health systems in the world. The spectrum of symptoms is variable and usually ranges from asymptomatic cases to severe manifestations involving multiple organ dysfunction accompanied by jaundice, hemorrhage, meningitis, and acute kidney injury that requires the need for intensive care assistance. Although early antibiotic treatment is usually effective, in severe cases it may require renal replacement therapy, invasive mechanical ventilation, vasoactive support, and invasive hemodynamic monitoring, increasing the risk of death. In Latin America, the real burden of acute kidney injury in this condition is unknown and may be underestimated due to the rapid progression of the disease, similar to other vector zoonoses, and the low coverage of diagnostic tests in primary care, especially in rural regions. Therefore, below, we review the clinical aspects and describe the scientific, clinical, and therapeutic evidence of acute kidney injury attributed to Leptospira spp. and its relevance in patients with severe leptospirosis in Latin America.
- 5 December 2023
- Published by MDPI AG in Preprints.org
Open AccessAcute Kidney Injury Associated with Severe Leptospirosis: Fatal Re-Emerging Disease in Latin-America
Leptospirosis is a re-emerging zoonotic disease that has had an unprecedented impact on most health systems in the world. The spectrum of symptoms is variable and usually ranges from asymptomatic cases to severe manifestations involving multiple organ dysfunction accompanied by jaundice, hemorrhage, meningitis, and acute kidney injury that requires the need for intensive care assistance. Although early antibiotic treatment is usually effective, in severe cases it may require renal replacement therapy, invasive mechanical ventilation, vasoactive support, and invasive hemodynamic monitoring, increasing the risk of death. In Latin America, the real burden of acute kidney injury in this condition is unknown and may be underestimated due to the rapid progression of the disease, similar to other vector zoonoses, and the low coverage of diagnostic tests in primary care, especially in rural regions. Therefore, below, we review the clinical aspects and describe the scientific, clinical, and therapeutic evidence of acute kidney injury attributed to Leptospira spp. and its relevance in patients with severe leptospirosis in Latin America.